Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420

  • Frank S. Lieberman
  • , Meihua Wang
  • , H. Ian Robins
  • , Christina I. Tsien
  • , Walter J. Curran
  • , Maria Werner-Wasik
  • , Ryan P. Smith
  • , Christopher Schultz
  • , Alan C. Hartford
  • , Peixin Zhang
  • , Minesh P. Mehta

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)878-886
Number of pages9
JournalInternational Journal of Radiation Oncology Biology Physics
Volume103
Issue number4
DOIs
StatePublished - Mar 15 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this